Can you provide the average price target for EXOSENS SAS stock?
19 analysts have analysed EXENS.PA and the average price target is 65.31 EUR. This implies a price increase of 2.05% is expected in the next year compared to the current price of 64.
EXOSENS SAS (EXENS.PA) Forecast, Price Target & Analyst Ratings
EPA:EXENS • FR001400Q9V2
Current stock price
64 EUR
-3.1 (-4.62%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EXOSENS SAS (EXENS.PA).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
€65.31
Upside
+ 2.05%
From current price of €64.00 to mean target of €65.31, Based on 19 analyst forecasts
Low
€55.55
Median
€65.79
High
€76.13
Price Target Revisions
1 Month
19.64%
3 Months
28.29%
Price Target Summary
19 Wall Street analysts provided a forecast for the next 12 months for EXENS.PA. The average price target is 65.31 EUR. This implies a price increase of 2.05% is expected in the next year compared to the current price of 64.
The average price target has been revised upward by 28.29% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
EXENS.PA was analyzed by 19 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about EXENS.PA.
In the previous month the buy percentage consensus was at a similar level.
EXENS.PA was analyzed by 19 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-12-12 | Berenberg | Maintains | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 27, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2026 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 291.819M 45.36% | 383.441M 31.40% | 468.187M 22.10% | 551.59M 17.81% | 626.61M 13.60% | 708.47M 13.06% | 790.24M 11.54% | 879.21M 11.26% | 826.96M -5.94% | 876.54M 6.00% | 929.12M 6.00% | |
| EBITDA YoY % growth | 80.53M 62.12% | 114.477M 42.15% | 145.27M 26.90% | 175.98M 21.14% | 205.2M 16.60% | 236.62M 15.31% | 281.23M 18.85% | 321.18M 14.21% | N/A | N/A | N/A | |
| EBIT YoY % growth | 49.598M 70.29% | 79.87M 61.03% | 105.746M 32.40% | 137.19M 29.74% | 163.48M 19.16% | 188.64M 15.39% | 241.68M 28.12% | 277.21M 14.70% | N/A | N/A | N/A | |
| Operating Margin | 17.00% | 20.83% | 22.59% | 24.87% | 26.09% | 26.63% | 30.58% | 31.53% | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A 50.07% | 1.94 30.76% | 2.29 17.95% | 2.69 17.35% | 3.32 23.24% | 3.83 15.53% | N/A | N/A | N/A |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
21.87%
EPS Next 5 Year
20.84%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
14.12%
Revenue Next 5 Year
13.02%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
27.47%
EBIT Next 5 Year
22.97%
EXOSENS SAS / EXENS.PA Forecast FAQ
Can you provide the upcoming earnings date for EXOSENS SAS?
EXOSENS SAS (EXENS.PA) will report earnings on 2026-04-27.
What is the expected long term growth rate for EXOSENS SAS (EXENS.PA)?
The expected long term growth rate for EXOSENS SAS (EXENS.PA) is 14.12%.